Navigation Links
Northern California Cancer Center's First-of-Its-Kind Research Reveals Low Socioeconomic Status Often Equals Poor Chance of Lymphoma Survival
Date:7/20/2009

Considerably higher risk of follicular lymphoma-related death in poorer neighborhoods may be linked to care required to address waxing and waning progression of disease

FREMONT, Calif., July 20 /PRNewswire-USNewswire/ -- The Northern California Cancer Center (NCCC) recently found that lower socioeconomic status is "significantly associated with substantially poorer survival" of follicular lymphoma in California.

Although survival rates for lymphomas have improved in recent years, not all groups are experiencing improvements. The NCCC team, headed by Theresa Keegan, Ph.D., found that among all patients diagnosed with follicular lymphoma in California, those in poorer neighborhoods had as much as a 37% increased risk of death from the disease, regardless of race/ethnicity, or the stage of their disease when diagnosed. The study results were published in the Journal of Clinical Oncology, June, 2009. NCCC's research is the first to look at socioeconomic levels and survival of this form of cancer.

Follicular lymphoma, the slow-growing, most common type of non-Hodgkin lymphoma, is a cancer of the immune system and white blood cells which affects men and women equally. The cancer involves the body's lymph nodes which fight infection and disease. It begins with an enlargement of the lymph nodes and symptoms can include fever, weight loss, sweating and fatigue. It is called "follicular" lymphoma because lymph nodes seen under microscopes display unusual rounded structures called "follicles."

Follicular lymphoma is known for its waxing and waning course. It may flare up and regress a number of times over years, which would require a continuing care program. The nature of the disease could make it difficult for people who may not be able to access effective treatment services due to their socioeconomic status.

About the Northern California Cancer Center:

The Northern California Cancer Center (www.nccc.org) is the only center in the country dedicated solely to cancer prevention research. It is recognized nationally as a leader in researching the causes and patterns of cancer across the population and improving the prevention and detection of cancer.

.


'/>"/>
SOURCE Northern California Cancer Center
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF
2. Bad News to Bad Bugs: Northern Antibiotics Develops Novel Polymyxins With Reduced Toxicity
3. Northern California Foot and Ankle Center Santa Rosa Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Research Trial
4. University of California Los Angeles Selects Velos eResearch
5. deCODE Receives California Clinical Laboratory License
6. Global Health Research Foundation Awarded $25,000 Grant From Westly Foundation to Study Asthma in Californias Central Valley
7. California Stem Cell Agency Exaggerated Its Role in Funding Key Research
8. New Conflict of Interest Violations Revealed at California Stem Cell Institute
9. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
10. Veto of Californias Condoms in Prisons Bill: "Politics Over Public Health," Says AHF
11. California Legislature Passes Historic HIV Testing Bill (AB 682); AHF Urges Governor to Sign Crucial Lifesaving Legislation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017 Research and Markets ... Pipeline and Market Prospects: Addressing Production Complexities Through Risk ... offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production Complexities ... in-depth assessment of the current trends in the global ...
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... From April ... of Urgent Care Medicine will host industry leaders for the annual spring Convention ... those in the industry adapt to the issues currently affecting urgent care and ...
(Date:4/28/2017)... ... April 28, 2017 , ... People are starting to ... “Wearing a hearing aid doesn’t have the stigma it had when great-grandpa wore his ... of Greater Boston, in a NALA North American Speaker Series (NASS) segment. ...
(Date:4/28/2017)... ... ... Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has published a ... does not. Yisrayl says with so many titles and names for the Creator, it’s ... with a little Scripture, backed with a lot of research, the truth is undeniable. ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... for the North East region. Côté has 20+ years of experience within the ... Phytomer, Côté worked with an array of high-end cosmetic brands, retail brands and ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... advanced nutraceutical supplements, through its Nova Skin Sciences division, recently announced the launch ... a moisturizer with the power of an anti-aging concentrate. , Anogeissus ...
Breaking Medicine News(10 mins):